NovoCure Limited

Novocure is an international oncology company that develops and commercializes Tumor Treating Fields, an innovative cancer therapy that uses alternating electric fields at specific frequencies to disrupt cancer cell division while sparing healthy tissue. Founded by Professor Yoram Palti, the company works with patients and clinicians to extend survival in some of the most aggressive forms of solid tumor cancer. Novocure operates across North America, Europe, the Middle East and Asia with more than 1,300 employees.